Pandemic Opening the Door for Widespread Genetic Testing

The COVID-19 pandemic accelerated adoption of an array of disruptive growth technologies, including e-commerce, fintech, and more. Healthcare innovation is part of that trend, and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is an exchange traded fund for investors to consider as the...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.